PEOPLE - Changes at JenaValve Technology:
This article was originally published in Clinica
Executive Summary
Germany's JenaValve Technology has established a scientific advisory board, appointing eight members with immediate effect. It is headed by Professor Hans-Reiner Figulla, a cardiologist and co-founder and inventor at the Munich-based minimally-invasive aortic valve replacement systems developer. The other members are: fellow co-founder and inventor Dr Markus Ferrari; stent catheter consultant Dr Younes Boudjemline (Necker Hospital, Paris); Professor Junbo Ge, co-chair of the Shanghai Institute of Cardiovascular Diseases and president of the Shanghai Society of Cardiology; Professor Martin Rothman, director of cardiac R&D at London's Barts hospital; Professor Ziyad Hijazi, of Chicago's Rush University; Professor Jan Gummert, director of cardiothoracic surgery at Friedrich Schiller University Jena, Germany; and Professor Horst Sievert, director of the CardioVascular Center, Frankfurt.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.